S'abonner

Distinct behavior of human Langerhans cells and inflammatory dendritic epidermal cells at tight junctions in patients with atopic dermatitis - 02/10/14

Doi : 10.1016/j.jaci.2014.08.001 
Kazue Yoshida, MD, PhD a, b, Akiharu Kubo, MD, PhD a, c, , Harumi Fujita, PhD a, d, Mariko Yokouchi, MD a, Ken Ishii, MD, PhD a, e, Hiroshi Kawasaki, MD, PhD a, Toshifumi Nomura, MD, PhD f, Hiroshi Shimizu, MD, PhD f, Keisuke Kouyama, MD, PhD g, Tamotsu Ebihara, MD, PhD a, Keisuke Nagao, MD, PhD a, Masayuki Amagai, MD, PhD a, c, d
a Department of Dermatology, Keio University School of Medicine, Tokyo, Japan 
c Keio-Maruho Laboratory of Skin Barriology, Keio University School of Medicine, Tokyo, Japan 
d KOSÉ Endowed Program for Skin Care and Allergy Prevention, Keio University School of Medicine, Tokyo, Japan 
g Center for Clinical Research, Keio University School of Medicine, Tokyo, Japan 
b Department of Dermatology, National Center for Child Health and Development, Tokyo, Japan 
e Department of Dermatology, Toho University School of Medicine, Tokyo, Japan 
f Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan 

Corresponding author: Akiharu Kubo, MD, PhD, Department of Dermatology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku, Tokyo 160-8582, Japan.

Abstract

Background

The stratum corneum and tight junctions (TJs) form physical barriers in the epidermis. Dendrites of activated Langerhans cells (LCs) extend beyond the TJs to capture external antigens in mice. LCs and inflammatory dendritic epidermal cells (IDECs) are observed in the skin of patients with atopic dermatitis (AD).

Objective

We sought to investigate the characteristics of LCs and IDECs and the distribution of their antigen capture receptors in relation to TJs in normal and AD skin.

Methods

We characterized the interactions of LCs and IDECs with TJs and the expression patterns of langerin and FcεRI by using whole-mount epidermal sheets from healthy subjects and patients with AD, ichthyosis vulgaris, and psoriasis vulgaris.

Results

As in mouse skin, activated LCs penetrate TJs in human skin. The number of LCs with TJ penetration increased approximately 5-fold in erythematous lesional skin of patients with AD but not in nonlesional skin of patients with AD or lesions of patients with ichthyosis vulgaris or psoriasis. In contrast, IDECs localized in the lower part of the epidermis, and their dendrites extended horizontally without penetration through TJs. Although langerin accumulated on the tips of dendrites of activated LCs, FcεRI was expressed diffusely on the cell surfaces on LCs and IDECs in lesional skin from patients with AD.

Conclusions

These findings highlight interesting differences between LCs and IDECs in epidermis of patients with AD, where LCs, but not IDECs, extend dendrites through the TJs, likely to capture antigens from outside the TJ barrier with a polarized distribution of langerin but not FcεRI. These behavioral differences between skin dendritic cells might reflect an important pathophysiology of AD.

Le texte complet de cet article est disponible en PDF.

Key words : Langerhans cell, inflammatory dendritic epidermal cell, tight junction, stratum corneum, atopic dermatitis, langerin, FcεRI

Abbreviations used : AD, Biotin-SH, 3D, DC, IDEC, IV, LC, SC, TJ, ZO-1


Plan


 Supported in parts by Grants-in-Aid for Scientific Research and “Promotion of Environmental Improvement for Independence of Young Researchers” program from the Ministry of Education, Culture, Sports, Science and Technology of Japan; a Health Labour Sciences Research Grant for Research on Allergic Diseases and Immunology from the Ministry of Health, Labour and Welfare of Japan; Research Grants for Life Sciences and Medicine from Keio University Medical Science Fund; a Keio University Grant-in-Aid for Encouragement of Young medical Scientists; the Mochida Memorial Foundation for Medical and Pharmaceutical Research; and a Research Grant from the Cosmetology Research Foundation.
 Disclosure of potential conflict of interest: A. Kubo has been supported by a Research Grant from the Cosmetology Research Foundation; the Mochida Memorial Foundation for Medical and Pharmaceutical Research; Research Grants for Life Sciences and Medicine from Keio University Medical Science Fund; Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and the “Promotion of Environmental Improvement for Independence of Young Researchers” program of the Ministry of Education, Culture, Sports, Science and Technology of Japan. M. Amagai has been supported by a Health Labour Sciences Research Grant for Research on Allergic Diseases and Immunology from the Ministry of Health, Labour and Welfare of Japan. The rest of the authors declare that they have no relevant conflicts of interest.


© 2014  American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 134 - N° 4

P. 856-864 - octobre 2014 Retour au numéro
Article précédent Article précédent
  • Identification of novel gene signatures in patients with atopic dermatitis complicated by eczema herpeticum
  • Lianghua Bin, Michael G. Edwards, Ryan Heiser, Joanne E. Streib, Brittany Richers, Clifton F. Hall, Donald Y.M. Leung
| Article suivant Article suivant
  • Eczematous sensitization, a novel pathway for allergic sensitization, can occur in an early stage of eczema
  • Kenji Matsumoto, Hirohisa Saito

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.